Reduceren van de4 kosten van de controle van patienten met niet-spier-invasief blaaskanker
Suspended
- Conditions
- Bladder Cancerbladder cancer, non-muscle invasive, surveillance, cystoscopy, urine testBlaaskanker, oppervlakkig blaaskanker, controles, cystoscopie, urine test
- Registration Number
- NL-OMON28752
- Lead Sponsor
- Erasmus MC
- Brief Summary
A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 450
Inclusion Criteria
patients under surveillance for recurrences after a NMIBC primary tumor
Exclusion Criteria
under 21 years of age
patients upgraded at reTUR to NMIBC
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 15% extra recurrences detected in maximal care arm; <br>40% percentage decrease in cystoscopies in optimal care arm; <br>costs of optimal care vs classic care: 4000 euro less; <br>
- Secondary Outcome Measures
Name Time Method lower stage recurrences in high-risk group